Abstract | BACKGROUND: With expanding applications and increasingly aggressive stress protocols, concerns about the safety of dobutamine stress echocardiography (DSE) have arisen. The purpose of this study was to analyse prospectively the safety, adverse event profile and complication rate of DSE. METHODS: Prospective data were recorded in a consecutive series of 474 patients undergoing DSE. Dobutamine was administered intravenously in graded infusion, each stage over 3 min, at 10, 20, 40 and, if required, 50 micrograms/kg/min. Atropine (1 mg) was administered thereafter if the response remained suboptimal. RESULTS: CONCLUSION:
|
Authors | T G Hennessy, M B Codd, G Kane, C McCarthy, H A McCann, D D Sugrue |
Journal | Coronary artery disease
(Coron Artery Dis)
1997 Mar-Apr
Vol. 8
Issue 3-4
Pg. 175-8
ISSN: 0954-6928 [Print] England |
PMID | 9237028
(Publication Type: Journal Article)
|
Chemical References |
- Cardiotonic Agents
- Dobutamine
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Angina Pectoris
(etiology)
- Arrhythmias, Cardiac
(etiology)
- Cardiotonic Agents
(adverse effects)
- Coronary Disease
(diagnostic imaging, physiopathology)
- Dobutamine
(adverse effects)
- Echocardiography
(adverse effects, methods)
- Electrocardiography
- Exercise Test
(adverse effects, methods)
- Female
- Humans
- Injections, Intravenous
- Male
- Middle Aged
- Prospective Studies
- Safety
|